Impact News +++ Navan (NAVN) Sued Over IPO Disclosures; Investors Face April 24 Deadline - Hagens Berman (PR Newswire) +++ NAVAN Aktie -4,27%

BIOTALYS Aktie

>BIOTALYS Aktienkurs

1.725 EUR +0.6% (TradegateBSX)

Ask: 1.855 EUR / 600 Stück

Bid: 1.7 EUR / 700 Stück

Tagesumsatz: 600 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

BIOTALYS Aktie über LYNX handeln

Intraday

1 Jahr

>BIOTALYS Performance

1 Woche: -5,7%

1 Monat: -33,3%

3 Monate: -48,0%

6 Monate: -62,9%

1 Jahr: -49,1%

laufendes Jahr: -48,0%

>BIOTALYS Aktie

Name:

BIOTALYS NV

Land:

Belgien

Sektor:

Chemie

ISIN/ Wkn:

BE0974386188 / A3CS50

Symbol/ Ticker:

86C (Frankfurt)

Kürzel:

FRA:86C, ETR:86C, 86C:GR

Index:

Webseite:

https://www.biotalys.com/

Profil:

Biotalys NV is an agricultural technology company developing protein-based biocontrol solutions for sustainable crop protection. The company specializes in biofungicides and bioinsecticides that target pests and pathogens such as botrytis, powdery mi..
>Volltext..

Marktkapitalisierung:

62.93 Mio. EUR

Unternehmenswert:

49.52 Mio. EUR

Umsatz:

EBITDA:

-16.65 Mio. EUR

Nettogewinn:

-15.11 Mio. EUR

Gewinn je Aktie:

-0.42 EUR

Schulden:

4.37 Mio. EUR

Liquide Mittel:

18.15 Mio. EUR

Operativer Cashflow:

-12.29 Mio. EUR

Bargeldquote:

3.37

Umsatzwachstum:

Gewinnwachstum:

9.19%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

BIOTALYS

Letzte Datenerhebung:

01.04.26

>BIOTALYS Kennzahlen

Aktien/ Unternehmen:

Aktien: -

Frei handelbar: -

Leerverk. Aktien: -

Rückkaufquote: -23.38%

Mitarbeiter: 63

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Strong buy

Kursziel: 289.53%

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: 3.25

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -50.74%

Eigenkaprendite: -75.33%

>BIOTALYS Peer Group

Chemie, Agrochemie

>BIOTALYS Chart & Kurs - Tradegate

>BIOTALYS News

24.03.26 - 07:03	Biotalys Announces New Dates for the Publication of its 2025 Annual Report and for its Annual Shareholders Meeting (GlobeNewswire EN)
	Biotalys announces that it will publish its annual report and financial results for the full year of 2025 on Wednesday, 29 April 2026 at 07:00 CEST....

17.03.26 - 07:03	Biotalys Announces Changes to its Board of Directors and Executive Committee (GlobeNewswire EN)
	Biotalys today announced changes to its board and management team....

24.02.26 - 18:03	Biotalys Notice of Publication 2025 Annual Report and Financial Results (GlobeNewswire EN)
	Biotalys today announces that it will publish its annual report and consolidated financial results for the full year of 2025 on Friday, 27 March 2026....

09.02.26 - 12:03	Biotalys Announces Intention to Strategically Refocus its Activities to Prioritize Lead Assets and Reduce Annual Cash Burn (GlobeNewswire EN)
	Biotalys announced its intention for a strategic refocus designed to concentrate resources on its highest-priority programs and streamline operations...

23.01.26 - 07:03	Biotalys and 21st.BIO Enter into Strategic Partnership to Advance Biocontrol Production (GlobeNewswire EN)
	Biotalys Provides Update on Its Plans to Fund Next Phase of Development Biotalys Provides Update on Its Plans to Fund Next Phase of Development...

02.12.25 - 11:06	Biotalys-Aktie legt nach EPA-Zulassung für erstes Bio-Fungizid zu/n (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

02.12.25 - 07:03	Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA (GlobeNewswire EN)
	U.S. Registration Marks a Significant Milestone as the First Protein-Based Biofungicide of its Kind to be Approved by the EPA U.S. Registration Marks a Significant Milestone as the First Protein-Based Biofungicide of its Kind to be Approved by the EPA...

03.11.25 - 16:27	XFRA: 86C: Wiederaufnahme/Resumption (XETRA)
	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIOTALYS NV 86C BE0974386188 AB/FROM ONWARDS 03.11.2025 16:19 CET...

31.10.25 - 10:48	Biotalys: Aktie springt nach positivem Votum der US-Behörde für erstes Biofungizid/n (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

31.10.25 - 07:03	EPA Issues Proposed Registration Decision for Biotalys′ EVOCA™ Biofungicide (GlobeNewswire EN)
	U.S. Environmental Protection Agency Initiates Public Participation Procedure U.S. Environmental Protection Agency Initiates Public Participation Procedure...

30.10.25 - 09:15	XFRA: 86C: Aussetzung/Suspension (XETRA)
	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL BIOTALYS NV 86C BE0974386188 BAW/UFN...

30.10.25 - 09:09	XFRA: INSTRUMENT_SUSPENSION - BE0974386188 (XETRA)
	Instrument ID [7792083] (86C - BE0974386188) suspended...

18.09.25 - 07:03	Biotalys Reports Half-Year 2025 Financial Results and Business Highlights (GlobeNewswire EN)
	Press release - regulated information Press release - regulated information...

29.08.25 - 07:03	Biotalys Provides Regulatory Review Update for EVOCA in the U.S. (GlobeNewswire EN)
	Inside information Inside information...

11.06.25 - 07:03	Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU (GlobeNewswire EN)
	US EPA projects taking a regulatory decision by end of September 2025; Dutch authorities finalise first phase of regulatory dossier for EVOCA in Europe US EPA projects taking a regulatory decision by end of September 2025; Dutch authorities finalise first phase of regulatory dossier for EVOCA in Europe...

26.05.25 - 07:03	Biotalys Appoints Luc Van fraeyenhoven as Chief Financial Officer (GlobeNewswire EN)
	Seasoned Financial Executive Will Lead Finance Operations as Biotalys Pushes Product Pipeline Toward Commercialization Seasoned Financial Executive Will Lead Finance Operations as Biotalys Pushes Product Pipeline Toward Commercialization...

20.05.25 - 07:03	Biotalys and AgroFresh Partner to Protect Fresh Produce (GlobeNewswire EN)
	Global leaders in sustainable agricultural innovation to develop biological solutions to reduce food waste Global leaders in sustainable agricultural innovation to develop biological solutions to reduce food waste...

25.03.25 - 07:03	Biotalys to Appoint Toni Bucci to its Board of Directors (GlobeNewswire EN)
	Seasoned Agriculture and Biotech Executive With a Passion to Feed the World Sustainably Seasoned Agriculture and Biotech Executive With a Passion to Feed the World Sustainably...

19.03.25 - 07:03	Biotalys Reports Full-Year 2024 Financial Results and Business Highlights (GlobeNewswire EN)
	Ghent, BELGIUM, March 19, 2025 (GLOBE NEWSWIRE) -- Press release – regulated information...

11.03.25 - 07:03	Biotalys Achieves Strong Results in Field Trials with Second Biofungicide (GlobeNewswire EN)
	BioFun-6 Candidate Shows Excellent Efficacy with Increased Potency BioFun-6 Candidate Shows Excellent Efficacy with Increased Potency...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Don′t marry, be happy. - Hera Lind

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram